Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;26(7):733-738.
doi: 10.1017/S1355617720000181. Epub 2020 Mar 5.

Episodic Memory and Hippocampal Volume Predict 5-Year Mild Cognitive Impairment Conversion in Healthy Apolipoprotein ε4 Carriers

Margaret Abraham  1 , Michael Seidenberg  1 , Dana A Kelly  1 , Kristy A Nielson  2   3 , John L Woodard  4 , J Carson Smith  5 , Sally Durgerian  3 , Stephen M Rao  6
Affiliations

Episodic Memory and Hippocampal Volume Predict 5-Year Mild Cognitive Impairment Conversion in Healthy Apolipoprotein ε4 Carriers

Margaret Abraham et al. J Int Neuropsychol Soc. 2020 Aug.

Abstract

Objective: The Apolipoprotein (APOE) ε4 allele increases the risk for mild cognitive impairment (MCI) and dementia, but not all carriers develop MCI/dementia. The purpose of this exploratory study was to determine if early and subtle preclinical signs of cognitive dysfunction and medial temporal lobe atrophy are observed in cognitively intact ε4 carriers who subsequently develop MCI.

Methods: Twenty-nine healthy, cognitively intact ε4 carriers (ε3/ε4 heterozygotes; ages 65-85) underwent neuropsychological testing and MRI-based measurements of medial temporal volumes over a 5-year follow-up interval; data were converted to z-scores based on a non-carrier group consisting of 17 ε3/ε3 homozygotes.

Results: At follow-up, 11 ε4 carriers (38%) converted to a diagnosis of MCI. At study entry, the MCI converters had significantly lower scores on the Mini-Mental State Examination, Rey Auditory Verbal Learning Test (RAVLT) Trials 1-5, and RAVLT Immediate Recall compared to non-converters. MCI converters also had smaller MRI volumes in the left subiculum than non-converters. Follow-up logistic regressions revealed that left subiculum volumes and RAVLT Trials 1-5 scores were significant predictors of MCI conversion.

Conclusions: Results from this exploratory study suggest that ε4 carriers who convert to MCI exhibit subtle cognitive and volumetric differences years prior to diagnosis.

Keywords: Alzheimer disease; Hippocampus; Longitudinal studies; MRI; Mild cognitive impairment; Risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest/Disclosure Statement

The authors have no conflict of interest to report.

References

    1. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, & Johns H (2015). Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement, 11(6), 718–726. doi: 10.1016/j.jalz.2015.05.016 - DOI - PubMed
    1. Carlesimo GA, Piras F, Orfei MD, Iorio M, Caltagirone C, & Spalletta G (2015). Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer’s disease. Alzheimers Dement (Amst), 1(1), 24–32. doi: 10.1016/j.dadm.2014.12.001 - DOI - PMC - PubMed
    1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, … Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261(5123), 921–923. doi: 10.1126/science.8346443 - DOI - PubMed
    1. Evans TE, Adams HHH, Licher S, Wolters FJ, van der Lugt A, Ikram MK, … Ikram MA (2018). Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia. Neuroimage, 178, 129–135. doi: 10.1016/j.neuroimage.2018.05.041 - DOI - PubMed
    1. Folstein MF, Folstein SE, & McHugh PR (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12(3), 189–198. doi: 10.1016/0022-3956(75)90026-6 - DOI - PubMed

Publication types

Substances